Literature DB >> 17332387

Oncology. Recruiting the cell's own guardian for cancer therapy.

Jean Marx.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332387     DOI: 10.1126/science.315.5816.1211

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  12 in total

1.  Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population.

Authors:  Ying-Xue Wang; Lei Zhao; Xiu-Yun Wang; Chang-Mei Liu; Su-Guo Yu
Journal:  Med Oncol       Date:  2011-11-26       Impact factor: 3.064

2.  Competitive binding between dynamic p53 transactivation subdomains to human MDM2 protein: implications for regulating the p53·MDM2/MDMX interaction.

Authors:  Bing Shan; Da-Wei Li; Lei Brüschweiler-Li; Rafael Brüschweiler
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

Review 3.  The structure-based design of Mdm2/Mdmx-p53 inhibitors gets serious.

Authors:  Grzegorz M Popowicz; Alexander Dömling; Tad A Holak
Journal:  Angew Chem Int Ed Engl       Date:  2011-02-21       Impact factor: 15.336

4.  Targeting wild-type and mutant p53 with small molecule CP-31398 blocks the growth of rhabdomyosarcoma by inducing reactive oxygen species-dependent apoptosis.

Authors:  Jianmin Xu; Laura Timares; Clay Heilpern; Zhiping Weng; Changzhao Li; Hui Xu; Joseph G Pressey; Craig A Elmets; Levy Kopelovich; Mohammad Athar
Journal:  Cancer Res       Date:  2010-08-03       Impact factor: 12.701

Review 5.  Radiation-induced cell death mechanisms.

Authors:  David Eriksson; Torgny Stigbrand
Journal:  Tumour Biol       Date:  2010-05-20

6.  Hepatocellular carcinoma: management of an increasingly common problem.

Authors:  Gary L Davis; Jane Dempster; James D Meler; Douglas W Orr; Mark W Walberg; Brian Brown; Brian D Berger; John K O'Connor; Robert M Goldstein
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-07

7.  MdmX promotes bipolar mitosis to suppress transformation and tumorigenesis in p53-deficient cells and mice.

Authors:  Zdenka Matijasevic; Heather A Steinman; Kathleen Hoover; Stephen N Jones
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

8.  CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice.

Authors:  Xiuwei Tang; Yucui Zhu; Lydia Han; Arianna L Kim; Levy Kopelovich; David R Bickers; Mohammad Athar
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

9.  Targeting mutant p53 shows promise for sunscreens and skin cancer.

Authors:  Wafik S El-Deiry
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 10.  Oncolytic virus therapy for cancer.

Authors:  Joe Goldufsky; Shanthi Sivendran; Sara Harcharik; Michael Pan; Sebastian Bernardo; Richard H Stern; Philip Friedlander; Carl E Ruby; Yvonne Saenger; Howard L Kaufman
Journal:  Oncolytic Virother       Date:  2013-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.